AstraZeneca drug Imfinzi fails as monotherapy for type of lung cancer Reuters Dec 19, 2022 Imfinzi, in a phase-III trial called 'Pearl', failed in patients whose tumour cells express high levels of PD-L1, or in a subgroup…
